Literature DB >> 34888830

Principles of Astrogliopathology.

Alexei Verkhratsky1,2, Baoman Li3, Caterina Scuderi4, Vladimir Parpura5.   

Abstract

The role of astrocytes in the nervous system pathology was early on embraced by neuroscientists at end of the nineteenth and the beginning of the twentieth century, only to be pushed aside by neurone-centric dogmas during most of the twentieth century. However, the last decade of the twentieth century and the twenty-first century have brought the astroglial "renaissance", which has put astroglial cells as key players in pathophysiology of most if not all disorders of the nervous system and has regarded astroglia as a fertile ground for therapeutic intervention.Astrocytic contribution to neuropathology can be primary, whereby cell-autonomous changes, such as mutations in gene encoding for glial fibrillary acidic protein, can drive the pathologic progression, in this example, Alexander disease. They can also be secondary, when astrocytes respond to a variety of insults to the nervous tissue. Regardless of their origin, being cell-autonomous or not, changes in astroglia that occur in pathology, that is, astrogliopathology, can be contemporary and arbitrary classified into four forms: (i) reactive astrogliosis, (ii) astrocytic atrophy with loss of function, (iii) pathological remodelling of astrocytes and (iv) astrodegeneration morphologically manifested as clasmatodendrosis. Inevitably, as with any other classification, this classification of astrogliopathology awaits its revision that shall be rooted in new discoveries and concepts.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Astrocyte; Astrocytic atrophy; Neuropathology; Pathological remodelling; Reactive astrogliosis

Mesh:

Year:  2021        PMID: 34888830      PMCID: PMC8999877          DOI: 10.1007/978-3-030-77375-5_3

Source DB:  PubMed          Journal:  Adv Neurobiol


  118 in total

1.  Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain.

Authors:  J R Goss; C E Finch; D G Morgan
Journal:  Neurobiol Aging       Date:  1991 Mar-Apr       Impact factor: 4.673

2.  Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury.

Authors:  Ulrika Wilhelmsson; Eric A Bushong; Diana L Price; Benjamin L Smarr; Van Phung; Masako Terada; Mark H Ellisman; Milos Pekny
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

Review 3.  Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators.

Authors:  Michael V Sofroniew
Journal:  Neuroscientist       Date:  2013-10-08       Impact factor: 7.519

4.  Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia.

Authors:  Martha S Windrem; Mikhail Osipovitch; Zhengshan Liu; Janna Bates; Devin Chandler-Militello; Lisa Zou; Jared Munir; Steven Schanz; Katherine McCoy; Robert H Miller; Su Wang; Maiken Nedergaard; Robert L Findling; Paul J Tesar; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2017-07-20       Impact factor: 24.633

Review 5.  Astrogliopathology in the infectious insults of the brain.

Authors:  Robert Zorec; Tatjana Avšič Županc; Alexei Verkhratsky
Journal:  Neurosci Lett       Date:  2018-08-07       Impact factor: 3.046

6.  Glial reaction in the hippocampal formation is highly correlated with aging in human brain.

Authors:  J P David; F Ghozali; C Fallet-Bianco; A Wattez; S Delaine; B Boniface; C Di Menza; A Delacourte
Journal:  Neurosci Lett       Date:  1997-10-10       Impact factor: 3.046

7.  Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques.

Authors:  Pranav Preman; Julia Tcw; Sara Calafate; An Snellinx; Maria Alfonso-Triguero; Nikky Corthout; Sebastian Munck; Dietmar Rudolf Thal; Alison M Goate; Bart De Strooper; Amaia M Arranz
Journal:  Mol Neurodegener       Date:  2021-09-25       Impact factor: 18.879

8.  Protective role of reactive astrocytes in brain ischemia.

Authors:  Lizhen Li; Andrea Lundkvist; Daniel Andersson; Ulrika Wilhelmsson; Nobuo Nagai; Andrea C Pardo; Christina Nodin; Anders Ståhlberg; Karina Aprico; Kerstin Larsson; Takeshi Yabe; Lieve Moons; Andrew Fotheringham; Ioan Davies; Peter Carmeliet; Joan P Schwartz; Marcela Pekna; Mikael Kubista; Fredrik Blomstrand; Nicholas Maragakis; Michael Nilsson; Milos Pekny
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-29       Impact factor: 6.200

Review 9.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

Review 10.  Astroglial atrophy in Alzheimer's disease.

Authors:  Alexei Verkhratsky; Jose Julio Rodrigues; Augustas Pivoriunas; Robert Zorec; Alexey Semyanov
Journal:  Pflugers Arch       Date:  2019-09-13       Impact factor: 3.657

View more
  2 in total

1.  Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer's Disease.

Authors:  Roberta Facchinetti; Marta Valenza; Chiara Gomiero; Giulia Federica Mancini; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Biomedicines       Date:  2022-05-26

2.  Altered Spinal Homeostasis and Maladaptive Plasticity in GFAP Null Mice Following Peripheral Nerve Injury.

Authors:  Ciro De Luca; Assunta Virtuoso; Sohaib Ali Korai; Raffaella Cirillo; Francesca Gargano; Michele Papa; Giovanni Cirillo
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.